NVO Stock Forecast : 2025-2035 Outlook

Novo Nordisk A/S is a strong Danish pharmaceutical company headquartered in Bagsværd, Copenhagen. This article gives you a detailed overview of the company, elaborates on all influencing factors of this stock, and then gives an idea about the NVO stock forecast for upcoming years.

WhatsApp Channel For Latest Update Join Now
Telegram Group Join Now

About The Novo Nordisk A/S (NYSE: NVO)

NOVO Nordisk was founded on Dec 21, 1923, this is a leading pharmaceutical company globally.

Novo Nordisk is managed by its major shareholding company, Novo Holdings A/S, which holds a 28% share of the company. Novo Nordisk manufactures and produces diabetes-related pharmaceutical products.

The main product of this company is the rug semaglutide which is used for the care of diabetes, this product is sold under the name of Ozempic and Rybelsus.

Novo Nordisk A/S Overview
DetailsInformation
Stock NameNovo Nordisk A/S
Stock SymbolNVO
Stock ExchangeNYSE
Market Cap288.48B USD
FounderHans Christian Hagedorn, August Krogh
Founded Year21 Dec 1923
HeadquarterBagsværd, Copenhagen. Denmark

Fundamentals of NVO Stock

This company’s market capitalization is 288.48B USD, and its average trading volume is 8.21M. Its yearly revenue growth is 31.26%, and its return on equity is 86.40%.

CompanyData
AVG Volume8.21M
Revenue Growth % (Yearly)31.26%
Net Income in USD83.68B
ROE86.40%
EPS18.62
P/B Ratio3.79
P/E Ratio
Dividend Yield
Total Equity106.56B
Net profit margin36.03
EBITDA Margin109.81B
Effective tax rate20.05%

History of the NVO Stock Price

NVO stock is listed on the New York Stock Exchange under the ticker symbol of NVO. NVO launched its initial public offering on 21 Dec 1984 and started from $0.12 per share.

Performance of NVO Stock
Courtesy: Google Finance Performance of NVO Stock

After the year of 2009, this stock continuously touched the upper circuit. The highest stock price of NVO is $142.74, this price touched in 2024. You can see these price graphs in the above image.

TimePer Share Value (USD)
Previous Close$83.07
Day Range$78.17 – $80.88
Before 5D$84.42
Before 1M$105.96
Before 6M$129.99
52 Week Range$78.17 – $148.15
Before 1Y$106.96
Before 5Y$30.66
1 Feb 1985$0.12
All time Max$142.74

Major Shareholder Of The NVO Stock

Novo Holdings A/S holds 28% share of this company which is the largest shareholder of NVO and you can see the remaining holding companies in the table below.

ShareholderShare %
 Novo Holdings A/S (Investment Company)28%
Novo Nordisk A/S0.65%
State Street Global Advisors Ltd.0.21%
Sjunde AP-fonden0.14%
 Eleva Capital SAS0.14%

Coming 1 to 10-Year NVO Stock Forecast Price Chart

You can see a stock forecast of NVO for the upcoming 1 to 10 years in detail. In this chart, you can see the minimum and maximum stock value for the first half and second half respectively.

YearMinimum & Maximum Per Stock Value (First term)Minimum & Maximum Per Stock Value (second term)
1 Year$105.67 & $127.49$124.95 & $158.42
2 Year$136.72 & $163.70$162.54 & $180.51
3 Year$175.41 & $215.67$213.57 & $195.48
4 Year$173.82 & $201.49$149.51 & $198.40
5 Year$129.35 & $159.67$165.50 & $192.77
6 Year$167.69 & $190.81$173.38 & $219.78
7 Year$182.59 & $198.95$212.35 & $232.94
8 Year$217.50 & $237.41$242.60 & $269.64
9 Year$265.40 & $277.18$272.60 & $293.49
10 Year$272.10 & $285.72$279.26 & $297.40

NVO Stock Forecast 2025

NVO stock forecast for 2025 is estimated to be $105.67 to $127.49 per share in the first half of the year. In the second half, this price could be hit up to $158.42 per share because of the sustainable growth of Ozempic and Wegovy.

2025Minimum Per Stock PriceMaximum per Stock Price
First term$105.67$127.49
Second term$124.95$158.42

NVO Stock Forecast 2026

The stock price prediction of NVO for 2026 is clearly shown in the table which is $136.72 to $163.70 per share in the first half.

In the second half, this price reached $180.51 per share because of the innovative ideas of NOVO Nordisk in 2026.

2026Minimum Per Stock PriceMaximum per Stock Price
First term$136.72$163.70
Second term$162.54$180.51

NVO Stock Forecast 2027

NVO stock price prediction for 2027 will be between $213.57 to $195.48. Obesity treatment of NOVO Nordisk attracts the entire market because the result of its products works like a panacea for Obesity.

2027Minimum Per Stock PriceMaximum per Stock Price
First term$175.41 $215.67
Second term$213.57$195.48

NVO Stock Forecast 2030

NVO stock forecast for 2030 is estimated to be $167.69 to $190.81 per share and its price will be reached at $219.78 in the second half.

2030Minimum Per Stock PriceMaximum per Stock Price
First term$167.69$190.81
Second term$173.38$219.78

NVO Stock Forecast 2025 To 2040 Price Chart

NVO stock forecast for 2025 to 2040 is presented in the table below, you can take an idea from this predicted price. There are 4 different types of data available for a year.

YearMinimum & Maximum Per Stock Value (First term)Minimum & Maximum Per Stock Value (second term)
2025$105.67 & $127.49$124.95 & $158.42
2026$136.72 & $163.70$162.54 & $180.51
2027$175.41 & $215.67$213.57 & $195.48
2028$173.82 & $201.49$149.51 & $198.40
2029$129.35 & $159.67$165.50 & $192.77
2030$167.69 & $190.81$173.38 & $219.78
2031$182.59 & $198.95$212.35 & $232.94
2032$217.50 & $237.41$242.60 & $269.64
2033$265.40 & $277.18$272.60 & $293.49
2034$272.10 & $285.72$279.26 & $297.40
2035$284.27 & $307.29$307.29 to $329.73
2040$392.18 & $402.76$398.74 & $429.71

Key Drivers for NVO Stock Growth

Several major key drivers for NVO stock will help the growth of NVO in the future.

Growing Demand for Diabetes Care: People face the problems of diabetes globally and the NOVO Nordisk products most effective in diabetes care such as Ozempic and Wegovy.

So if the demand for diabetes care increases in the future then the growth of this company is also increase.

Obesity Drug Market Expansion: Obesity drug market expansion is also helping the growth of NOVO Nordisk because its product Ozempic is successfully occupying the entire market in this sector.

Research and Development: NOVO continuously makes a huge investment in Research and Development so this also helps to produce new panacea products and then directly helps for the growth of this company.

2019 to 2023 Financial Chart of NVO Stock

If we take a look at the NVO stock yearly profit then we can see this company continuously generating profit in increasing ways. The profit of this company in 2023 was $83.68B which was an increase from $55.53B in 2022.

Financials of NOVO Nordisk
Financials of NOVO Nordisk

As you can see the profit of this company is increasing same as the revenue also increasing year by year. Last year revenue of this company was $232.26B which was an increase from $176.95B as previous year.

YearRevenue Of NVO StockProfit of NVO StockTotal Assets of NVO Stock
2019$122.02B$38.95B$125.68B
2020$126.95B$42.14B$144.92B
2021$140.80B$47.76B$194.51B
2022$176.95B$55.53B$241.26B
2023$232.26B$83.68B$314.49B

You Can Check – MARA Stock Forecast: Projections From 2025 To 2040

Challenges & Risk of NVO Stock

I explain the growth drivers of this stock but several challenges are also available and you must know about these challenges before investing in this stock.

Competition: Many times, you will see rivals launch products that directly impact the profit of already existing products. So competition is a big challenge and risk for the growth of NVO stock.

Economic Uncertainty: Currency fluctuations and the global economic downturn impact international sales and the result is growth of the company is as slow as previous growth.

R&D Failures: If the trial of research and development goes in the wrong way or continuously fails then this impact goes negative for the growth of NOVO Nordisk.

Conclusion

NOVO Nordisk has been a leading player in the field of diabetes care for the past years and also successfully dominated this field. So for long-term investment, this stock can be profitable.

However, there are many types of challenges and risks also available but NVO has much potential and it will tackle these challenges easily in the future.

FAQs

What is the stock price prediction for NVO in 2025?

The stock price prediction for NVO in 2025 will be $124.95 & $158.42.

What is the target price for NVO stock?

The target price for NVO stock in the last of 2025 is expected to reach at $158.42 per share.

What are the major growth drivers for NVO stock?

The demand for diabetes care is the major growth driver for NVO stock because NOVO products are dominating diabetes at the global level.

Can NVO stock reach $300 by 2035?

Yes, according to the present market trends and business growth, analysts predict that NVO stock hit $307.29 to $329.73 per share in the year 2035.

What risks should investors consider before investing in NVO?

There are several risks involved like regulatory challenges, economic downturn, and the competition are also high in this industry.

Leave a Comment